Anthony S. Prokopowicz

Author

Also Known As

A. S. PROKOPOWICZ, Anthony Prokopowicz, Anthony S Prokopowicz, Anthony S. Prokopowicz, Anthony S. Prokopowicz III, Anthony S. Prokopowicz, III

Publications

601

Citations

H-Index

Concepts

All Affiliations

Boehringer Ingelheim (United States)Boehringer Ingelheim (Germany)Boehringer Ingelheim (France)Boehringer Ingelheim (Japan)

About

Anthony S. Prokopowicz is an author at Boehringer Ingelheim (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	270
2	Natural Sciences	6	6	231
3	Biochemistry	5	5	213
4	Chemical Biology	2	2	117
5	Cell Biology	1	1	45

Anthony S. Prokopowicz

Publications

595

Citations

H-Index

Page 1

	Year	Citations
Three Mechanistically Distinct Kinase Assays Compared: Measurement of Intrinsic ATPase Activity Identified the Most Comprehensive Set of ITK Inhibitors Mohammed A. Kashem, Richard M. Nelson, Jeffrey D. Yingling, SLAS DISCOVERY	2006	132
Discovery of potent and selective PKC-θ inhibitors Charles L. Cywin, Georg Dahmann, Anthony S. Prokopowicz, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryDrug TargetMedicineRational Drug Design	2006	69
Hit to Lead Account of the Discovery of a New Class of Inhibitors of Pim Kinases and Crystallographic Studies Revealing an Unusual Kinase Binding Mode Kevin Qian, Lian Wang, Charles L. Cywin, Journal of Medicinal Chemistry Pim KinasesPim-2 SarMolecular BiologyLead IdentificationChemical Biology	2009	69
Evolution of the Thienopyridine Class of Inhibitors of IκB Kinase-β: Part I: Hit-to-Lead Strategies Tina M. Morwick, Angela Berry, Janice R. Brickwood, Journal of Medicinal Chemistry	2006	67
Discovery of 2-Phenylamino-imidazo[4,5-<i>h</i>]isoquinolin-9-ones: A New Class of Inhibitors of Lck Kinase Roger J. Snow, Mario Cardozo, Tina M. Morwick, Journal of Medicinal Chemistry	2002	63
Discovery and SAR of novel Naphthyridines as potent inhibitors of spleen tyrosine kinase (SYK) Charles L. Cywin, Baoping Zhao, Daniel W. McNeil, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ChemistryDrug TargetBiochemistryNatural Sciences	2003	48
Optimization of 2-Phenylaminoimidazo[4,5-<i>h</i>]isoquinolin-9-ones: Orally Active Inhibitors of lck Kinase Daniel R. Goldberg, Tanja Butz, Mario Cardozo, Journal of Medicinal Chemistry Pharmaceutical ScienceImmunologyCell DeathImmunologic MechanismImmunotherapy	2003	45
Isoquinolinone synthesis by SNAr reaction: a versatile route to imidazo[4,5-h]isoquinolin-9-ones Roger J. Snow, Tanja Butz, Abdelhakim Hammach, Tetrahedron Letters BiochemistryNatural SciencesOrganic ChemistryChemistrySnar Reaction	2002	34
Substituted 2H-isoquinolin-1-ones as potent Rho-kinase inhibitors: Part 2, optimization for blood pressure reduction in spontaneously hypertensive rats John D. Ginn, Todd Bosanac, Rhonda Chen, Bioorganic & Medicinal Chemistry Letters HypertensionMedicinal ChemistryPart 2Blood Pressure ReductionPhysiology	2010	22
4-Trifloxy-9-SEM-β-Carboline: Preparation and Synthetic Utility Carl A. Busacca, Magnus Eriksson, Yong Qiang Dong, The Journal of Organic Chemistry Medicinal ChemistryPharmaceutical ChemistryNatural SciencesAltmetric Attention ScoreRidgebury Road	1999	18

Page 1